Physician profile
John Gorski
NPI 1760877518
$3,208.24
in general payments reported to CMS, 2019-2025
22 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $47.33 · 2023: $186 · 2024: $1,178 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,982.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,294.06 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $562.03 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $175.72 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.44 | 2021-2024 | Ofev |
| Pulmonx Corporation | $118.84 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Abbvie INC. | $88.18 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $86.45 | 2024-2025 | Acthar |
| Amgen INC. | $83.13 | 2023-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $80.25 | 2024-2025 | Aralast, Glassia |
| Harmony Biosciences LLC | $75.04 | 2024-2025 | |
| Verona Pharma, INC. | $74.29 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $70.12 | 2024 | Yupelri |
| Sumitomo Pharma America, INC. | $62.85 | 2024 | Gemtesa |
| Philips North America LLC | $60.25 | 2025 | Vest Therapy Und |
| Lilly USA, LLC | $59.59 | 2021-2025 | Zepbound |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $33.58 | 2025 | Smartvest |
| Baxter Healthcare | $33.09 | 2025 | Hillrom - Monarch Airway Clearance System |
| Insmed, INC. | $30.86 | 2025 | Arikayce |
| Inspire Medical Systems, INC. | $24.43 | 2024 | Inspire |
| Viatris Specialty LLC | $18.99 | 2025 | Yupelri |
| Esperion Therapeutics, INC. | $17.59 | 2021 | |
| Axsome Therapeutics, INC. | $14.46 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gorski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.